Press Release August 18, 2021Werewolf Therapeutics Inks Solid Tumor Trial Collaboration With Merck 0 0 Share
Company Ticker News August 17, 2021Apple, GM, Kroger, AbbVie, Merck, Bristol Myers Squibb, Biogen — How Warren Buffett's Berkshire Adjusted Its Portfolio In Q2 0 0 Share
Company Ticker News August 16, 2021Pfizer And Merck: Two Long-Term Laggards In A Momentum Market, As Pfizer Gets A Catalyst From Covid-19 0 0 Share
Press Release August 14, 2021FDA Approves Merck's Hypoxia-Inducible Factor-2 Alpha (HIF-2α) Inhibitor WELIREG™ (belzutifan) for the Treatment of Patients With Certain Types of Von Hippel-Lindau (VHL) Disease-Associated Tumors 0 0 Share
Press Release August 12, 2021FDA Approves KEYTRUDA® (pembrolizumab) Plus LENVIMA® (lenvatinib) Combination for First-Line Treatment of Adult Patients With Advanced Renal Cell Carcinoma (RCC) 0 0 Share
Press Release August 10, 2021FDA Grants Priority Review to Merck's Supplemental Biologics License Application for KEYTRUDA® (pembrolizumab) as Adjuvant Therapy in Certain Patients With Renal Cell Carcinoma (RCC) Following Surgery 0 0 Share
Press Release August 10, 2021FDA Accepts Application for Merck's KEYTRUDA® (pembrolizumab) as Single Agent for Certain Patients With MSI-H/dMMR Advanced Endometrial Carcinoma 0 0 Share
Company Ticker News August 10, 2021Moderna Is Now Valued Higher Than 130-Year Old Vaccine Giant Merck 0 0 Share
Company Ticker News August 8, 2021MERCK Kommanditgesellschaft auf Aktien (MKGAF) CEO Belen Garijo on Q2 2021 Results - Earnings Call Transcript 0 0 Share
